Combinatorial siRNA Polyplexes for Receptor Targeting

Area of Science:

• Biotechnology
• Nanomedicine
• Cancer Research

Background:

• Small interfering RNA (siRNA) holds therapeutic potential for cancer by targeting specific genes.
• Developing effective and tumor-specific siRNA delivery systems remains a significant challenge in cancer therapy.
• Folate receptors are overexpressed in various cancer cells, making them attractive targets for drug delivery.

Purpose of the Study:

• To design and synthesize novel folate-conjugated combinatorial siRNA polyplexes for targeted cancer therapy.
• To evaluate the efficiency of these polyplexes in delivering siRNA to folate receptor-expressing tumors.
• To assess the gene silencing capabilities and tumor-killing effects of the developed delivery system.

Main Methods:

• Solid-phase-supported synthesis of sequence-defined oligomer platform for polyplex formation.
• Conjugation of folate to the oligomer platform to create targeted carriers.
• In vitro and in vivo evaluation of polyplex formation, siRNA delivery, and gene silencing efficacy.
• Assessment of receptor-directed cancer cell killing.

Main Results:

• Successful generation of folate-conjugated targeted combinatorial siRNA polyplexes.
• Demonstrated efficient siRNA delivery and gene silencing in folate receptor-expressing tumors.
• Observed effective receptor-directed cell killing in cancer cells in vitro and in vivo.

Conclusions:

• Folate-conjugated siRNA polyplexes represent a promising strategy for targeted cancer therapy.
• The developed delivery system enables efficient cytosolic and systemic delivery of siRNA to tumors.
• This approach offers a potential platform for developing novel cancer treatments with enhanced specificity.